Pure Red Cell Aplasia (PRCA) is a rare blood disorder characterized by the selective failure of the bone marrow to produce red blood cells, leading to severe anemia. The term "pure" refers to the fact that only red blood cell precursors are affected, while other blood cell types, such as white blood cells and platelets, are typically produced normally. PRCA can be acquired or congenital and is often associated with immune system dysfunction, infections, or other underlying diseases.
Pure Red Cell Aplasia (PRCA) is characterized by the failure of the bone marrow to produce red blood cells, resulting in severe anemia. Unlike other types of anemia, where a shortage of red blood cells occurs due to loss or destruction, PRCA is caused by a failure in the production of these cells. The condition can be congenital (present from birth) or acquired (developing later in life).
PRCA can be classified into two main types:
Congenital PRCA is an inherited condition where individuals are born with the inability to produce red blood cells. This type is extremely rare and often manifests in infancy or early childhood.
Acquired PRCA occurs when the immune system attacks and destroys the red blood cell precursors in the bone marrow, leading to a halt in production. This form is more common and can be associated with various conditions, including autoimmune diseases, infections, or drug side effects.
The causes of PRCA can vary depending on whether the condition is congenital or acquired. Common causes include:
The main symptoms of PRCA are related to anemia and include:
These symptoms arise due to the body’s lack of red blood cells, which are responsible for carrying oxygen throughout the body.
Early and accurate diagnosis of PRCA is essential for effective treatment. Dr. Rahul Bhargava follows a comprehensive approach to diagnosis, which typically includes:
The treatment for PRCA depends on the underlying cause and the type of PRCA. Common treatment options include:
For acquired PRCA caused by autoimmune disorders, immunosuppressive drugs such as corticosteroids, azathioprine, or cyclosporine are often used to suppress the immune system and prevent it from attacking red blood cell precursors.
In severe cases, red blood cell transfusions may be required to increase the number of red blood cells temporarily until the condition improves.
For patients with PRCA related to thymoma, surgical removal of the thymus (thymectomy) may be recommended.
Dr. Rahul Bhargava is a leading hematologist in India, specializing in complex blood disorders like Pure Red Cell Aplasia. Here’s why patients choose him:
India offers high-quality medical care at a fraction of the cost compared to Western countries. The cost of PRCA treatment varies based on the specific interventions required. On average:
These estimates can vary based on individual patient needs and the chosen healthcare facility.